STOK

Stoke Therapeutics Inc (STOK)

US
$ 9.76-1.21%

Price Chart

Key Statistics

Market Cap
$ 527.41M
P/E Ratio
0.00
Revenue (TTM)
$ 36.56M
Volume
580.62K
52W High
$ 17.58
52W Low
$ 5.35
Dividend Yield
0.00%
Beta
1.20

Technicals

50-Day MA
8.0828
200-Day MA
11.301
52 Week High
17.58
52 Week Low
5.35

About STOK

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Employees
128
Headquarters
Bedford, MA
CEO
Dr. Arthur O. Tzianabos Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg